Known proved BKV nephropathy
Hypersensitivity to everolimus, sirolimus or excipient
Concomitant treatment by leflunomide, cidofovir, sirolimus, Millepertuis (Hypericum Perforatum)
Pregnant or lactating women
Women of child bearing potential unless they are using a birth control method

NCT03216967_exc_T1
Qualifier
proved
NCT03216967_exc_T2
Condition
BKV nephropathy
NCT03216967_exc_T3
Condition
Hypersensitivity
NCT03216967_exc_T4
Drug
everolimus
NCT03216967_exc_T5
Drug
sirolimus
NCT03216967_exc_T6
Drug
excipient
NCT03216967_exc_T7
Scope
everolimus, sirolimus or excipient
NCT03216967_exc_T8
Temporal
Concomitant
NCT03216967_exc_T10
Drug
leflunomide
NCT03216967_exc_T11
Drug
cidofovir
NCT03216967_exc_T12
Drug
sirolimus
NCT03216967_exc_T13
Drug
Millepertuis
NCT03216967_exc_T9
Drug
Hypericum Perforatum
NCT03216967_exc_T14
Scope
leflunomide, cidofovir, sirolimus, Millepertuis (Hypericum Perforatum)
NCT03216967_exc_T15
Condition
Pregnant
NCT03216967_exc_T16
Condition
lactating
NCT03216967_exc_T17
Person
women
NCT03216967_exc_T18
Person
Women
NCT03216967_exc_T19
Condition
child bearing potential
NCT03216967_exc_T20
Negation
unless
NCT03216967_exc_T21
Procedure
birth control method